Females with DMD gene variations, even in the absence of skeletal muscle symptoms, have an estimated 7.3–16.7% lifetime risk of developing cardiomyopathy, characterised by left ventricular dilatation and decreased shortening fraction [5, 6]. The gene discussed is DMD; the disease is cardiomyopathy.